113 related articles for article (PubMed ID: 11550716)
1. Endovascular radiotherapy for stenosis after percutaneous transluminal coronary angioplasty.
Ulutin HC; Pak Y
Radiat Med; 2001; 19(4):175-9. PubMed ID: 11550716
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary irradiation for the prevention of restenosis.
Weinberger J; Simon AD
Curr Opin Cardiol; 1997 Sep; 12(5):468-74. PubMed ID: 9352174
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
Sheppard R; Eisenberg MJ; Donath D; Meerkin D
Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
[TBL] [Abstract][Full Text] [Related]
5. Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.
Deiner C; Shagdarsuren E; Schwimmbeck PL; Rosenthal P; Loddenkemper C; Rauch U; Pauschinger M; Dietz R; Schultheiss HP; Dechend R; Pels K
Cardiovasc Res; 2007 Jul; 75(1):195-204. PubMed ID: 17434466
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
[TBL] [Abstract][Full Text] [Related]
7. Endovascular brachytherapy for the prevention of restenosis.
Wilenzick RM; Kuske RR; Jenkins S
J Invasive Cardiol; 1999 Feb; 11(2):90-2. PubMed ID: 10745489
[No Abstract] [Full Text] [Related]
8. [Long-term effects and complications of intravascular brachytherapy].
Ma C; Xu C; Zhang X; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):502-5. PubMed ID: 15250167
[TBL] [Abstract][Full Text] [Related]
9. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?].
Langberg CW; Solheim S; Hagen S
Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis.
Cha DH; Ajani AE; Cheneau E; Waksman R
J Invasive Cardiol; 2002 Jul; 14(7):432-7. PubMed ID: 12082202
[TBL] [Abstract][Full Text] [Related]
11. High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.
Geiger MH; Ludwig J; Burckhard R; Scheinert D; Müller RG; Daniel WG; Sauer R; Strnad V
Strahlenther Onkol; 2006 Jan; 182(1):9-15. PubMed ID: 16404515
[TBL] [Abstract][Full Text] [Related]
12. Basis of endovascular radiation therapy in human coronary arteries.
Condado JA
Semin Interv Cardiol; 1997 Jun; 2(2):115-8. PubMed ID: 9546991
[TBL] [Abstract][Full Text] [Related]
13. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
Chen Y; Geng J; Tian J; Yin D; Chen S
Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
[No Abstract] [Full Text] [Related]
15. Intracoronary brachytherapy in the porcine model: a different animal.
Fischell TA; Virmani R
Circulation; 2001 Nov; 104(20):2388-90. PubMed ID: 11705812
[No Abstract] [Full Text] [Related]
16. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
[TBL] [Abstract][Full Text] [Related]
17. [Brachytherapy after coronary interventions: current state and future perspectives].
Naber CK; Kaiser CA; Sauerwein W; Meusers P; Eggebrecht H; Haude M; Erbel R; Baumgart D
Z Kardiol; 2003 Jan; 92(1):1-15. PubMed ID: 12545296
[TBL] [Abstract][Full Text] [Related]
18. Intravascular brachytherapy to prevent restenosis: dosimetric considerations.
Campos L; Stabin M
Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):429-39. PubMed ID: 12146694
[TBL] [Abstract][Full Text] [Related]
19. [Effect on dose owing to source displacement in coronary endovascular brachytherapy].
Xu ZY; Zhang LA; Yuan SY; Dai GF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):193-6. PubMed ID: 12905719
[TBL] [Abstract][Full Text] [Related]
20. [Edge effect and late thrombosis -- inevitable complications of vascular brachytherapy?].
Schiele TM; Staber L; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Klauss V
Z Kardiol; 2002 Nov; 91(11):869-78. PubMed ID: 12442189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
